Back to results
US 2024/0180875 A1Published application
Treatment of Autism Spectrum Disorders with Ergothioneine, Selenoneine, or Combinations Thereof
AssigneeAutism Therapeutics Inc.
InventorDexian Dou
Life of this patent
Estimating the term…
Abstract
A method of treatment of autism spectrum disorders comprising ergothioneine (ET), selenoneine (SeET), or combinations thereof. The methods may include the use of edible compositions comprising ergothioneine (ET), selenoneine (SeET), or combinations thereof.
Claims20
A method of treatment of autism spectrum disorders comprising:
- administering a therapeutically effective amount of ergothioneine (ET) without other active ingredients in a dosage range of from about 0.1 to about 75 mg/kg body weight (bw) per day for at least one month to a human subject;
- wherein a CARS 2 score of the human subject is reduced by at least one point.
(canceled)
(canceled)
(canceled)
(canceled)
A method of treatment of autism spectrum disorders comprising administering a therapeutically effective amount of ergothioneine (ET) and optionally selenoneine (SeET) to a human subject;
- wherein the therapeutically effective amount of ergothioneine (ET) and optionally selenoneine (SeET)-is administered in a dosage range of from about 0.45 μg to about 800 mg/kg body weight (bw) per day;
- and
- wherein a CARS-2 score of the human subject is reduced by at least 1.5.
Dependencies are inferred from the claim text.